Michael Sofia
Chief Tech/Sci/R&D Officer at ARBUTUS BIOPHARMA CORPORATION
Net worth: 5 M $ as of 2024-05-30
Network origin in Michael Sofia first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.
29
| Subsidiary | Pharmaceuticals: Other | 29 |
| Public Company | Biotechnology | 17 | |
Baruch S. Blumberg Institute
4
| Non-Profit Organization | 4 | |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Bristol-Myers Squibb Pharma Research Labs LLC researches and develops drugs and related pharmaceutical products. The company is headquartered in San Diego, CA
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Transcell Technology, Inc.
 Transcell Technology, Inc. Industrial MachineryProducer Manufacturing Transcell Technology, Inc. manufactures load cells, postal scales, precision balances, and industrial scales. It offers digital scale, load cells, process weighing, and scale parts and accessories. The company was founded in 1981 and is headquartered in Buffalo Grove, IL.
1
| Private Company | Industrial Machinery | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Sofia via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact General Counsel | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member Chief Executive Officer Chief Executive Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| MEDIGENE AG | Biotechnology | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
| Rice University | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| Simon Fraser University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree | |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Human Resources Officer | |
Gilead Sciences Europe Ltd.
 Gilead Sciences Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences Europe Ltd. develops and commercializes pharmaceuticals. The company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gilead Sciences International Ltd.
 Gilead Sciences International Ltd. Other Consumer ServicesConsumer Services Founded in 1996, Gilead Sciences International Ltd. is a subsidiary of Gilead Sciences, Inc. The company is based in Cambridge, UK. Gilead Sciences International is focused on developing and delivering medications that advance the treatment of life-threatening diseases. Contact information, addresses, and directions for all of Gilead U.S. locations can be found on their website. Additionally, contact details for Gilead offices in other locations are also available. | Other Consumer Services | Director/Board Member Director/Board Member | |
| Hepatitis B Foundation | Director/Board Member Founder Chairman | ||
| KITE PHARMA INC | Biotechnology | Director of Finance/CFO Corporate Secretary Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chairman Chief Executive Officer Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Chief Executive Officer | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | President Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member Director/Board Member Chairman | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal President | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Medical Distributors | Director/Board Member Director/Board Member | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistics
International
| United States | 33 |
| Canada | 9 |
| United Kingdom | 6 |
| Germany | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Distribution Services | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 393 |
| Corporate Officer/Principal | 191 |
| Independent Dir/Board Member | 102 |
| Chairman | 76 |
| Undergraduate Degree | 65 |
Most connected contacts
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| G. Steven Burrill | 44 |
| Myrtle Potter | 42 |
| Frank Torti | 35 |
| Robin Washington | 34 |
| Elizabeth Tallett | 28 |
| Daniel Burgess | 28 |
| Carol Brosgart | 25 |
| Alan Roemer | 21 |
| Herbert Conrad | 21 |
| Michael Jeffrey Abrams | 16 |
| Adam Daniel Cutler | 16 |
| Fredric D. Price | 16 |
| Brett Pletcher | 15 |
| Keith Manchester | 15 |
- Stock Market
- Insiders
- Michael Sofia
- Company connections
